1. Home
  2. LYNX vs IMTX Comparison

LYNX vs IMTX Comparison

Compare LYNX & IMTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lyntris Inc. Common Stock

LYNX

Lyntris Inc. Common Stock

N/A

Current Price

$11.60

Market Cap

1.3B

Sector

Industrials

ML Signal

N/A

IMTX

Immatics N.V.

N/A

Current Price

$7.10

Market Cap

1.3B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
LYNX
IMTX
Founded
2018
N/A
Country
United States
Germany
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.3B
IPO Year
2026
2020

Fundamental Metrics

Financial Performance
Metric
LYNX
IMTX
Price
$11.60
$7.10
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
7
9
Target Price
★ $19.67
$16.40
AVG Volume (30 Days)
347.4K
★ 1.1M
Earning Date
11-04-2026
11-16-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$35.28
N/A
Revenue Next Year
$34.08
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$10.27
$6.65
52 Week High
$14.64
$12.41

Technical Indicators

Market Signals
Indicator
LYNX
IMTX
Relative Strength Index (RSI) 47.11 40.20
Support Level $10.49 $6.65
Resistance Level $13.74 $7.95
Average True Range (ATR) 0.60 0.43
MACD 0.12 0.05
Stochastic Oscillator 64.00 35.38

Price Performance

Historical Comparison
LYNX
IMTX

About LYNX Lyntris Inc. Common Stock

Lyntris Inc is a defense technology company that develops connectivity solutions for military applications. Its products consist of interconnected subsystems designed to support defense and military customers in detecting threats, making decisions, and responding to operational requirements across multi-domain environments. The company serves U.S. and allied nation military customers. Its solutions are deployed across three core missions: Maritime Domain Awareness; Air & Missile Defense; and Space ISR & Resilient Communications. Maximum revenue is derived from the Maritime Domain Awareness business, which includes solutions focused on maritime monitoring, tracking and analysis that support government and defense customers in maintaining situational awareness across maritime environments.

About IMTX Immatics N.V.

Immatics NV is a clinical-stage biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.

Share on Social Networks: